shivaani kummar ohsu email shivaani kummar ohsu email

Sign up to receive the latest news, updates and stories from the OHSU Foundation in your inbox. Trisha Silbernagel, RN, BSN, early-phase clinical trial unit manager, checks equipment on Aug. 23, 2021. Visit thebilling andinsurancesection of our sitefor more information. Shivaani Kummar. (Getty Images), Communications Manager, OHSU Knight Cancer Institute, Husband-wife team from Stanford University tapped to lead two cancer programs at OHSU, OHSU leading effort to make cancer trials more inclusive, Making Hepatitis C care easier when treatment seems impossible, Pill for skin disease also curbs excessive drinking, OHSU clinical trial tests exercise for multiple sclerosis treatment. BYLINE. L Fong, A Hotson, JD Powderly, M Sznol, RS Heist, TK Choueiri, S Kummar, A Chen, RE Parchment, RJ Kinders, J Ji, JE Tomaszewski, AF Farago, MS Taylor, RC Doebele, VW Zhu, S Kummar, AI Spira, S Kummar, M Gutierrez, ER Gardner, E Donovan, K Hwang, EJ Chung, Clinical Cancer Research 13 (18), 5411-5417. Share on email. & Kummar, S. Research output: Contribution to journal Comment/debate peer-review, Research output: Contribution to journal Review article peer-review, Research output: Contribution to journal Article peer-review, Powered by Pure, Scopus & Elsevier Fingerprint Engine 2023 Elsevier B.V, We use cookies to help provide and enhance our service and tailor content. 2001-2022 Oregon Health & Science University. Yourinsurancecompany will also be able to inform you of any copayments, coinsurance, or deductibles that will be your responsibility. This conversation is with Shivaani Kummar, MD (professor, oncology), who joined the Stanford faculty in January 2015. The institute is involved with more than 400 clinical trials, including 113 early-phase trials. OHSU Knight Cancer Institute leaders include some of the most distinguished doctors and scientists in the world. Hung, M.D. Administrative Coordinator, Denise Hopkins Due to Covid-19 pandemic, the 2020 Symposium was postponed to 2021. . What sort of projects are you working on right now? All these new agents have shown promising anticancer activity in laboratory testing and are now being evaluated in patients. This center will be for the community, and we hope people will reach out to be a part of it. (44 Ratings, Privacy Notice: We use technologies, such as cookies, to customize content and advertising, to analyze traffic to the site and to provide a better overall experience to our users. Shivaani Kummar, M.D., FACP, head of the Division of Hematology and Medical Oncology in the OHSU School of Medicine and co-director of the Knight Cancer Institute's You can also correspond with Dr. Shivaani Kummar through mail at her mailing address at 3181 Sw Sam Jackson Park Rd, , Portland, Oregon - 97239-3011 (mailing address contact number . Nature reviews Drug discovery 9 (11), 843-856. 11 Jun 2022. 2001-2023 OHSU. Our patients in research studies can come in for their initial blood work and continue through their post treatment observation all in one place and are surrounded by a team of experts guiding them through the process.. Vol.49 No.07. A Drilon, TW Laetsch, S Kummar, SG DuBois, UN Lassen, GD Demetri, New England Journal of Medicine 378 (8), 731-739. Select a country/territory to view shared publications and projects. The purpose of the study is to learn more about the study drug, VIP152, in combination with pembrolizumab in people with advanced or . Most recently, he was the director for Stanford SRI Drug Discovery and Development Program, and he trained with Nobel laureate Herb Brown at Purdue University. Within our Center for Experimental Therapeutics, Knight Cancer Institute, we have multiple ongoing projects trying to identify new ways to target cancer. Each faculty member comes with a unique background, which often propels him or her into medicine and a particular . However, high costs, long development t The new early-phase research unit completes this expansion in the building. what was bolivar's ultimate goal? OHSU is an equal opportunity affirmative action institution. 1 - 20 out of 67 Results for "Shivaani Kummar" 67 Results Select All . Shivaani Kummar, M.D., will lead the Division of Hematology and Medical Oncology in the OHSU School of Medicine, overseeing more than 90 faculty members. Developing new treatments for cancer is a complex, multidisciplinary process that truly takes a village. OHSU is an equal opportunity affirmative action institution. Study Purpose. They say they shared an interest in cancer drug discovery and development that grew after their marriage. Shivaani Kummar: STUDY00022986: An open-label, multicenter Phase I dose escalation study to characterize safety, tolerability, preliminary antitumor activity, pharmacokinetics and maximum tolerated dose of VIP152 (BAY 1251152) as monotherapy or combination therapy in subjects with advanced cancer . S Kummar, A Chen, J Ji, Y Zhang, JM Reid, M Ames, L Jia, M Weil, K Do, D Wilsker, J Ji, J Zlott, T Freshwater, RJ Kinders, J Collins, AP Chen, Journal of Clinical Oncology 33 (30), 3409. Dr. Kummar joined the OHSU Knight Cancer Institute from Stanford University in July 2020. I am humbled and inspired by the courage, grace and feeling of altruism that I find in each and every patient who chooses to participate in these trials. Uncategorized . The center is designed to advance innovation efforts within the Knight Cancer Institute to discover and develop new treatments for cancer, from early phase clinical trials, to drug development. (h.c.), Ph.D., FAACR Director of CEDAR Sadik Esener, Ph.D. Director of precision oncology and SMMART Gordon Mills, M.D.,Ph.D. In Brief. What is the importance of philanthropy to your work? Keep me signed in. Shivaani Kummar, M.D., will lead the Division of Hematology and Medical Oncology in the OHSU School of Medicine, overseeing more than 90 faculty members. This trial will study tisotumab vedotin to find out whether it is an effective treatment for certain solid tumors and what side effects (unwanted effects) may occur. She also leads the division of hematology & medical oncology in the OHSU School of Medicine. Cancer and Medical Oncology and Hematology, Cancer, Cancer and Blood Disorders and Blood Diseases, Cancer and Blood Disorders, Hematology and Oncology, Cancer, Cancer and Blood Disorders and Benign Blood Disorders, Cancer, Hematology Oncology and Medical Oncology and Hematology, Cancer, Cancer and Blood Disorders and Medical Oncology and Hematology, Cancer, Blood Diseases and Medical Oncology and Hematology, Cancer, Cancer and Blood Disorders and Bladder Cancer, Cancer, Hematology Oncology and Blood Cancers, Hospice and Palliative Care, Internal Medicine and Psychiatry, Hospice and Palliative Care and Palliative Care, Hospice and Palliative Care, Internal Medicine and Geriatrics, Sarah Lowry, D.N.P., ACNP-BC, AOCNP, ACHPN, Thomas G. DeLoughery, M.D., M.A.C.P., FAWM. Expanding scientific knowledge is a key mission of OHSU, Oregons only academic health center. Charles D. Blanke, M.D., F.A.C.P., F.A.S.C.O. . Combining PARP Inhibitor with Immunotherapy - Does the Promise of Preclinical Data Translate to Clinic? She currently practices at Oregon Health And Sciencs University Primary Care Clinic and is affiliated with Stanford Health Care. Office 3181 SW Sam Jackson Park Rd Portland, OR 97239 Phone+1 503-280-1223 Is this information wrong? BAL0891 . February 17, 2023 In Brief Edith Mitchell named enterprise vice president for cancer disparities at Jefferson SKCC . Local: (503) 228-1730 | Toll Free: (800) 462-6608 Equipment. She runs early phase clinical trials evaluating new treatments while ensuring highest standards of patient safety. By Shivaani Kummar, Antoine Italiano, Marcia S Brose, Josh Carlson | American Journal of Managed Care ABSTRACTThe tropomyosin receptor kinase (TRK) family of proteins is encoded by neurotrophic tyrosine receptor kinase (NTRK) genes and has a role in the development and normal functioning of the nervous system. Dr. Shivaani Kummar Dr. Kummar was recently appointed as Division Chief of Hematology and Oncology, and co-Director of the Center for Experimental Therapeutics, at the Oregon Health and Science University in Portland, Oregon. Bergan, R., Coussens, L., McWeeney, S., Spellman, P., Streeter, P., Winters-Stone, K., Bagby, G., Mori, M., Corless, C., Harrington, C., Hoatlin, M., Koop, D., Magun, B., Druker, B., Shannon, J. Shivaani Kummar (Principal Investigator, PI). OHSU 'Mary Crowley Cancer . Email: trials@ohsu.edu Call: 503-494-1080 Across OHSU, doctors and researchers are reimagining early disease detection. 12 Reviews). Our ability to collaborate with academics and industries across the globe will be paramount to our success in developing new drugs for patients. Notice of Privacy Practices Shivaani Kummar, Lisa Coussens named deputy directors of OHSU Knight. Increasing patient participation in oncology clinical trials, A Novel Artificial IntelligencePowered Method for Prediction of Early Recurrence of Prostate Cancer after Prostatectomy and Cancer Drivers, Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue Sarcomas, Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer. . They have a high school-aged daughter and middle school-aged son. Will you join us. February 17, 2023 In Brief Edith Mitchell named enterprise vice president for cancer disparities at Jefferson SKCC Cited by. middlesex county community college nursing program nj Email: trials@ohsu.edu Call: 503-494-1080 Oregon Health & Science University. 23() 'Oregon Health & Science University Knight Cancer Institute(OHSU)' BAL0891 1 Shivaani Kummar (Principal Investigator, PI), OHSU 'Mary Crowley Cancer Research . Claire Yoshida, M.S.N., A.C.N.S.-B.C., A.C.H.P.N. Dr. Kummar completed a residency at Emory University. shivaani kummar ohsu email. Together their goal is to find a cure for cancer. Overall: 4.7 out of 5 OHSU HOSPITAL AND CLINICS - (Acute Care) 3181 SW SAM JACKSON PARK ROAD We also share information about your use of our site with our trusted social media, advertising and analytics partners. Dr. OHSU researchers lead innovation and passion through new discoveries, comradery of the OHSU research community and the drive to improve peoples health and well-being. Get to know some of the resear. 2001-2023 OHSU. Dr. Kummar is a cancer specialist whose focus is to bring new discoveries to the clinic, developing new treatments for cancer. Clinical trials Drug development oncology. This new unit allows us to centralize everything in a setting designed for a patients convenience and comfort, said Patrick McCormick, M.B.A., vice president of oncology services in the Knight Cancer Institute. Shivaani Kummar, M.D., FACP Expertise Cancer Special focus Medical Oncology and Hematology Email this page Print this page About me Dr. Kummar is a cancer specialist whose focus is to bring new discoveries to the clinic, developing new treatments for cancer. Dr. Shivaani Kummar is an oncologist in Palo Alto, California and is affiliated with OHSU Hospital. Patients and Methods. The Division of Hematology and Medical Oncology is headed by Shivaani Kummar, M.D., FACP and composed of many sections: Classical Hematology Community Oncology Hematologic Malignancies Palliative Care Portland VA Research Solid Tumor Stem Cell Transplantation Administration Section head Shivaani Kummar, M.D., FACP Professor of Medicine, OHSU. Only fill in if you are not human. Shivaani Kummar (Principal Investigator, PI), OHSU Mary Crowley Cancer Research, Montefiore Medical Center 4 1 . If you proceed in scheduling an appointment and your healthinsurancebenefits do not participate with OHSU providers, your out of pocket liability may be higher. Each study answers scientific questions and tries to find better ways to prevent, diagnose or treat diseases like cancer. The Knight Cancer Institutes Center for Experimental Therapeutics (CET) represents multidisciplinary collaborations among scientists, physicians and engineers across OHSU. Dr. Shivaani Kummar is an oncologist practicing in Bethesda, MD. She accepts multiple insurance plans. SHIVAANI KUMMAR, 207RX0202X - Medical Oncology Doctors & Physicians in PORTLAND, OR. By continuing you agree to the use of cookies. (h.c.), Ph.D., FAACR. And to train and inspire the next generation of doctors and scientists. Accepting new patients Drukers approach to team science is incorporated throughout the institutes infrastructure. Shivaani Kummar Stanford University Medical Center - PMWC Precision Medicine World Conference Speaker Profile M.D., Professor of Medicine and Radiology, Stanford University; Director, Phase I Clinical Research Program-Medical Oncology; Director, Translational Oncology Program At Stanford Shivaani Kummar Biography Year; Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. February 17, 2023. Faculty and staff recruitment information. At the end of the day, we need to develop better treatment for cancer patients and the only way to build that is through collaboration within OHSU and with other academic centers, biotech and pharma companies., Team science can be a buzz word. Seventeen patients with desmoid tumors received PF-03084014 150 mg orally twice a day in 3-week cycles. The OHSU Knight Cancer Institute has expanded its cancer research and care facilities to include a unit dedicated to serving patients participating in early-phase clinical trials. This philanthropy-fueled research revolution is already saving lives. Articles Cited by Public access. OHSU is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. Dive into details by clicking on the dots or, Knight Cancer Translational Oncology Program, Calculated based on number of publications stored in Pure and citations from Scopus, PQ3: Age-related immune deviation and cancer outcome, [18F]-AraG -PET imaging to evaluate immunological response to checkpoint inhibitor therapy (CKI) in patients with advanced solid tumors, Understanding the origins of rapid recurrence of pancreatic cancer after resection. Notice of Privacy Practices We are thrilled he is able to co-lead this new venture. Notice of Privacy Practices Cancer Early Detection Advanced Research Center, Adolescent and Young Adult Oncology Program, Social and Emotional Side Effects of Cancer, International Alliance for Early Cancer Detection (ACED), Lisa M. Coussens, M.D. Early-phase trials are the first step in testing promising new medications and methods, and can offer patients early access to new and possibly better treatments. The provider is located at 3181 Sw Sam Jackson Park Rd Portland, Or 97239 and the phone number is (503) 314-7168 Which is Dr. Shivaani Kummar specialty? Shivaani Kummar is a Hematology & Medical Oncology Head at Oregon Health & Science University based in Portland, Oregon.